Taraboletti G - Search Results

1

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.

Taraboletti G, Rusnati M, Ragona L, Colombo G. Taraboletti G, et al. Oncotarget. 2010 Nov;1(7):662-673. doi: 10.18632/oncotarget.200. Oncotarget. 2010. PMID: 21317461 Free PMC article. Review.

2

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.

Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R. Taraboletti G, et al. Cell Growth Differ. 1997 Apr;8(4):471-9. Cell Growth Differ. 1997. PMID: 9101093

3

Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.

Taraboletti G, Benelli R, Borsotti P, Rusnati M, Presta M, Giavazzi R, Ruco L, Albini A. Taraboletti G, et al. J Pathol. 1999 May;188(1):76-81. doi: 10.1002/(SICI)1096-9896(199905)188:1<76::AID-PATH312>3.0.CO;2-A. J Pathol. 1999. PMID: 10398144

4

Angiogenesis and angiogenesis inhibitors in cancer.

Giavazzi R, Taraboletti G. Giavazzi R, et al. Among authors: taraboletti g. Forum (Genova). 1999 Jul-Sep;9(3):261-72. Forum (Genova). 1999. PMID: 10504172 Review.

5

Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.

Rusnati M, Taraboletti G, Urbinati C, Tulipano G, Giuliani R, Molinari-Tosatti MP, Sennino B, Giacca M, Tyagi M, Albini A, Noonan D, Giavazzi R, Presta M. Rusnati M, et al. Among authors: taraboletti g. FASEB J. 2000 Oct;14(13):1917-30. doi: 10.1096/fj.99-0902com. FASEB J. 2000. PMID: 11023976

6

p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.

Vikhanskaya F, Bani MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, Marabese M, Giavazzi R, Broggini M, Taraboletti G. Vikhanskaya F, et al. Among authors: taraboletti g. Oncogene. 2001 Nov 1;20(50):7293-300. doi: 10.1038/sj.onc.1204896. Oncogene. 2001. PMID: 11704858

7

Antiangiogenic and antivascular therapy for cancer.

Taraboletti G, Margosio B. Taraboletti G, et al. Curr Opin Pharmacol. 2001 Aug;1(4):378-84. doi: 10.1016/s1471-4892(01)00065-0. Curr Opin Pharmacol. 2001. PMID: 11710736 Review.

8

Thrombospondin-1: an inhibitor of angiogenesis.

Taraboletti G. Taraboletti G. Haemostasis. 2001;31 Suppl 1:23-4. Haemostasis. 2001. PMID: 11990468 No abstract available.

9

Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.

Margosio B, Marchetti D, Vergani V, Giavazzi R, Rusnati M, Presta M, Taraboletti G. Margosio B, et al. Among authors: taraboletti g. Blood. 2003 Dec 15;102(13):4399-406. doi: 10.1182/blood-2003-03-0893. Epub 2003 Aug 28. Blood. 2003. PMID: 12947001 Free article.

10

Modelling approaches for angiogenesis.

Taraboletti G, Giavazzi R. Taraboletti G, et al. Eur J Cancer. 2004 Apr;40(6):881-9. doi: 10.1016/j.ejca.2004.01.002. Eur J Cancer. 2004. PMID: 15120043 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page